126 related articles for article (PubMed ID: 37772565)
21. Outcomes for Colorectal Cancer Cases With Peritoneal Metastases Treated With Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A Comparative Analysis of Survival Between Peritoneal Carcinomatosis Scores - PCI in a Single Centre.
Barat S; Wijayawardana R; Morris D
Anticancer Res; 2023 Aug; 43(8):3529-3538. PubMed ID: 37500168
[TBL] [Abstract][Full Text] [Related]
22. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma.
Piso P; Bektas H; Werner U; Schlitt HJ; Kubicka S; Bornscheuer A; Manns M; Klempnauer J
Eur J Surg Oncol; 2001 Apr; 27(3):286-90. PubMed ID: 11373107
[TBL] [Abstract][Full Text] [Related]
23. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
[TBL] [Abstract][Full Text] [Related]
24. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
[TBL] [Abstract][Full Text] [Related]
25. Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer.
Shen P; Thomas CR; Fenstermaker J; Aklilu M; McCoy TP; Levine EA
J Gastrointest Cancer; 2014 Sep; 45(3):268-75. PubMed ID: 24452995
[TBL] [Abstract][Full Text] [Related]
26. Peritonectomy for peritoneal carcinomatosis: long-term outcomes from a single Brazilian institution.
Akaishi E; Teixeira F; Katayama M; Mizumoto N; Costa FP; Buzaid AC; Hoff PM
World J Surg; 2009 Apr; 33(4):835-9; discussion 840. PubMed ID: 19169741
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
[TBL] [Abstract][Full Text] [Related]
28. Lymph node positive pseudomyxoma peritonei.
Sugarbaker PH; Chang D
Eur J Surg Oncol; 2022 Dec; 48(12):2369-2377. PubMed ID: 35941031
[TBL] [Abstract][Full Text] [Related]
29. Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery?
Delhorme JB; Dupont-Kazma L; Addeo P; Lefebvre F; Triki E; Romain B; Meyer N; Bachellier P; Rohr S; Brigand C
Int J Surg; 2016 Jan; 25():98-105. PubMed ID: 26607853
[TBL] [Abstract][Full Text] [Related]
30. Role of CRS and HIPEC in appendiceal and colorectal malignancies: Indian experience.
Gupta N; Asif S; Gandhi J; Rajpurohit S; Singh S
Indian J Gastroenterol; 2017 Mar; 36(2):126-130. PubMed ID: 28393331
[TBL] [Abstract][Full Text] [Related]
31. Perioperative outcomes of cytoreductive surgery for tumours of colorectal or appendiceal origin with ovarian involvement.
Wagstaff JFR; Flood MP; Mohan H; McBain RD; McNally O; Apte SS; McCormick J; Guerra GR; Heriot AG; Warrier SK
J Surg Oncol; 2023 Jul; 128(1):66-74. PubMed ID: 36942464
[TBL] [Abstract][Full Text] [Related]
32. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
Ihemelandu C; Mavros MN; Sugarbaker P
Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
[TBL] [Abstract][Full Text] [Related]
33. Indication of peritonectomy for peritoneal dissemination.
Yonemura Y; Tsukiyama G; Miyata R; Sako S; Endou Y; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Miura M; Hagiwara A; Li Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2306-11. PubMed ID: 21224556
[TBL] [Abstract][Full Text] [Related]
34. Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis.
Glockzin G; Gerken M; Lang SA; Klinkhammer-Schalke M; Piso P; Schlitt HJ
BMC Cancer; 2014 Nov; 14():807. PubMed ID: 25369730
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for appendiceal and colorectal peritoneal metastases.
Enblad M; Graf W; Birgisson H
Eur J Surg Oncol; 2018 Jul; 44(7):997-1005. PubMed ID: 29576463
[TBL] [Abstract][Full Text] [Related]
36. [Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
An SL; Ji ZH; Li XB; Liu G; Zhang YB; Gao C; Zhang K; Zhang XJ; Yan GJ; Yan LJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):434-441. PubMed ID: 37217351
[No Abstract] [Full Text] [Related]
37. Association of Systemic Chemotherapy Approaches With Outcomes in Appendiceal Peritoneal Metastases.
Hanna DN; Macfie R; Ghani MO; Hermina A; Mina A; Cha DE; Bailey CE; Cohen N; Labow D; Golas B; Sarpel U; Idrees K; Magge D
J Surg Res; 2023 Apr; 284():94-100. PubMed ID: 36563453
[TBL] [Abstract][Full Text] [Related]
38. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches.
Chang SC; Fingerhut A; Chen WT
Surg Oncol; 2022 Aug; 43():101766. PubMed ID: 35430126
[TBL] [Abstract][Full Text] [Related]
39. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia.
Alzahrani N; Ferguson JS; Valle SJ; Liauw W; Chua T; Morris DL
ANZ J Surg; 2016 Nov; 86(11):937-941. PubMed ID: 26179296
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC.
Graf W; Cashin PH; Ghanipour L; Enblad M; Botling J; Terman A; Birgisson H
Ann Surg Oncol; 2020 Jan; 27(1):293-300. PubMed ID: 31571052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
